共 50 条
- [31] Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment with a Prospective Post-Marketing Surveillance Study Drugs - Real World Outcomes, 2019, 6 : 27 - 35
- [33] Safety and efficacy of bexarotene for Japanese patients with cutaneous T-cell lymphoma: Real-world experience from post-marketing surveillance JOURNAL OF DERMATOLOGY, 2022, 49 (02): : 253 - 262
- [34] Advancing drug safety science by integrating molecular knowledge with post-marketing adverse event reports CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2022, 11 (05): : 540 - 555
- [37] Torsade de pointes associated with chloroquine, hydroxychloroquine, and azithromycin: a retrospective analysis of individual case safety reports from VigiBase European Journal of Clinical Pharmacology, 2021, 77 : 1513 - 1521
- [40] SAFETY OF QUINOLONES - ANALYSIS OF CLINICAL-TRIALS AND POST-MARKETING SURVEY DATA REVIEWS OF INFECTIOUS DISEASES, 1989, 11 : S1411 - S1411